Middle East & Africa Gastroparesis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

No. of Pages: 101    |    Report Code: TIPRE00024819    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Gastroparesis Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Gastroparesis Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Gastroparesis Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing prevelance of Diabetes Mellitus
5.2 Market Opportunities
  • 5.2.1 Surging Clinical Trials
5.3 Future Trends
  • 5.3.1 Technological Advancements and incresaing research on gastric stimulation
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Gastroparesis Market Regional Analysis

6.1 Middle East & Africa Gastroparesis Market Overview
6.2 Middle East & Africa Gastroparesis Market Revenue 2018-2027 (US$ Million)
6.3 Middle East & Africa Gastroparesis Market Forecast Analysis

7. Middle East & Africa Gastroparesis Market Analysis – by Type

7.1 Idiopathic
  • 7.1.1 Overview
  • 7.1.2 Idiopathic: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Diabetic
  • 7.2.1 Overview
  • 7.2.2 Diabetic: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Post-Surgical
  • 7.3.1 Overview
  • 7.3.2 Post-Surgical: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Gastroparesis Market Analysis – by Drug Class

8.1 Prokinetic Agents
  • 8.1.1 Overview
  • 8.1.2 Prokinetic Agents: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Botulinum Toxin Injections
  • 8.2.1 Overview
  • 8.2.2 Botulinum Toxin Injections: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Antiemetic Agents
  • 8.3.1 Overview
  • 8.3.2 Antiemetic Agents: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9. Middle East & Africa Gastroparesis Market Analysis – by Distribution Channel

9.1 Retail Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Antiemetic Agents: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Hospital Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Antiemetic Agents: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10. Middle East & Africa Gastroparesis Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Gastroparesis Market Breakdown, by Key Country, 2021 and 2027 (%)
  • 10.1.1.1 Middle East & Africa Gastroparesis Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Gastroparesis Market Breakdown, by Type
    • 10.1.1.1.2 South Africa: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.1.3 South Africa: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Gastroparesis Market Breakdown, by Type
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel
  • 10.1.1.3 UAE: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Gastroparesis Market Breakdown, by Type
    • 10.1.1.3.2 UAE: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.3.3 UAE: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market Breakdown, by Type
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Gastroparesis Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Gastroparesis Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Allergan Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Ipca Laboratories Ltd.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Johnson and Johnson Services, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Pfizer Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Middle East & Africa Gastroparesis Market

  1. Allergan Plc
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Ipca Laboratories Ltd.
  4. Johnson and Johnson Services, Inc.
  5. Pfizer Inc.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD
middle-east-and-africa-gastroparesis-market